These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24584104)

  • 1. Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration.
    Ezinga M; Wetzels JF; Bosch ME; van der Ven AJ; Burger DM
    Antivir Ther; 2014; 19(8):765-71. PubMed ID: 24584104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.
    Nishijima T; Komatsu H; Higasa K; Takano M; Tsuchiya K; Hayashida T; Oka S; Gatanaga H
    Clin Infect Dis; 2012 Dec; 55(11):1558-67. PubMed ID: 22955427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative exposure of TDF is associated with kidney tubulopathy whether it is currently used or discontinued.
    Nishijima T; Mutoh Y; Kawasaki Y; Tomonari K; Kikuchi Y; Gatanaga H; Oka S;
    AIDS; 2018 Jan; 32(2):179-188. PubMed ID: 29028660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study.
    Hassan MO; Duarte R; Mabayoje VO; Dickens C; Lasisi AO; Naicker S
    BMC Nephrol; 2020 Oct; 21(1):436. PubMed ID: 33066744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study.
    Rodríguez-Nóvoa S; Labarga P; Soriano V; Egan D; Albalater M; Morello J; Cuenca L; González-Pardo G; Khoo S; Back D; Owen A
    Clin Infect Dis; 2009 Jun; 48(11):e108-16. PubMed ID: 19400747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.
    Gatanaga H; Tachikawa N; Kikuchi Y; Teruya K; Genka I; Honda M; Tanuma J; Yazaki H; Ueda A; Kimura S; Oka S
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):744-8. PubMed ID: 16910829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.
    Labarga P; Barreiro P; Martin-Carbonero L; Rodriguez-Novoa S; Solera C; Medrano J; Rivas P; Albalater M; Blanco F; Moreno V; Vispo E; Soriano V
    AIDS; 2009 Mar; 23(6):689-96. PubMed ID: 19262355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
    Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
    AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
    Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
    AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
    Salvaggio SE; Giacomelli A; Falvella FS; Oreni ML; Meraviglia P; Atzori C; Clementi EGI; Galli M; Rusconi S
    BMC Infect Dis; 2017 Jun; 17(1):396. PubMed ID: 28583112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal tubular dysfunction associated with tenofovir therapy.
    Mitra S; Priscilla R; Rajeev K; Sauradeep S; Rajkumar S; Cherian AO
    J Assoc Physicians India; 2014 Jul; 62(7):580-2. PubMed ID: 25672029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of tenofovir treatment.
    Rodriguez-Novoa S; Labarga P; Soriano V
    Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
    Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
    HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir.
    Casado JL; Bañón S; Santiuste C; Serna J; Guzman P; Tenorio M; Liaño F; del Rey JM
    AIDS; 2016 Jan; 30(2):231-9. PubMed ID: 26684820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity.
    Vrouenraets SM; Fux CA; Wit FW; Garcia EF; Furrer H; Brinkman K; Hoek FJ; Abeling NG; Krediet RT; Reiss P;
    AIDS; 2011 Nov; 25(17):2149-55. PubMed ID: 21857491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenofovir disoproxil fumarate-associated nephrotoxicity in HIV-infected patients: a prospective controlled study.
    Woratanarat K; Kanjanabuch T; Suankratay C
    J Med Assoc Thai; 2013 Apr; 96(4):432-9. PubMed ID: 23691697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
    Kinai E; Hanabusa H
    AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.
    Judd A; Boyd KL; Stöhr W; Dunn D; Butler K; Lyall H; Sharland M; Shingadia D; Riordan A; Gibb DM
    AIDS; 2010 Feb; 24(4):525-34. PubMed ID: 20139752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary beta-2 microglobulin and alpha-1 microglobulin are useful screening markers for tenofovir-induced kidney tubulopathy in patients with HIV-1 infection: a diagnostic accuracy study.
    Nishijima T; Shimbo T; Komatsu H; Takano M; Tanuma J; Tsukada K; Teruya K; Gatanaga H; Kikuchi Y; Oka S
    J Infect Chemother; 2013 Oct; 19(5):850-7. PubMed ID: 23467792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir-associated renal and bone toxicity.
    Woodward CL; Hall AM; Williams IG; Madge S; Copas A; Nair D; Edwards SG; Johnson MA; Connolly JO
    HIV Med; 2009 Sep; 10(8):482-7. PubMed ID: 19459988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.